HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/3/F514    most recent 00101.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (20) Citing Articles via Google Scholar Google Scholar Articles by Yu, F. Articles by Price, P. M. Search for Related Content PubMed PubMed Citation Articles by Yu, F. Articles by Price, P. M.

EDITORIAL FOCUS

Identification of the functional domain of p21^WAF1/CIP1 that protects cells from cisplatin cytotoxicity

Departments of Physiology and Biophysics and Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Submitted 16 March 2005 ; accepted in final form 14 April 2005

The p21 cyclin-dependent kinase (cdk) inhibitor protects cells from cisplatin cytotoxicity in vivo and in vitro. However, the mechanism of protection is not known. Separate p21 domains are known to interact with several different proteins having proapoptotic functions. To investigate the mechanism of protection by p21, we have constructed adenoviruses encoding the different domains of p21. We were able to localize the protective activity to a region of 54 amino acids containing the cyclin-cdk interacting moiety. Other protein binding domains of p21, including the NH₂-terminal procaspase-3 interactive region and the COOH-terminal region containing the proliferating cell nuclear antigen binding domain and the nuclear localization signal, had little protective effect on cisplatin cytotoxicity. The dependence of cisplatin cytotoxicity on cdk2 activity was also demonstrated because 1) cisplatin caused a marked increase in cdk2 activity, which was prevented by the p21 expression adenovirus, and 2) a cdk2 dominant-negative adenovirus also protected cells from cisplatin-induced apoptosis. Thus the data suggest that the mechanism of p21 protection is by direct inhibition of cdk2 activity and that cisplatin-induced apoptosis is caused by a cdk2-dependent pathway.

kidney proximal tubular cells; apoptosis; p21 cyclin kinase inhibitor; cdk2

This article has been cited by other articles:

				R. A. Zager Uremia induces proximal tubular cytoresistance and heme oxygenase-1 expression in the absence of acute kidney injury Am J Physiol Renal Physiol, February 1, 2009; 296(2): F362 - F368. [Abstract] [Full Text] [PDF]

				M. Jiang and Z. Dong Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 300 - 307. [Abstract] [Full Text] [PDF]

				F. Yu, J. Megyesi, and P. M. Price Cytoplasmic initiation of cisplatin cytotoxicity Am J Physiol Renal Physiol, July 1, 2008; 295(1): F44 - F52. [Abstract] [Full Text] [PDF]

				D. Sheikh-Hamad Cisplatin-induced cytoxicity: is the nucleus relevant? Am J Physiol Renal Physiol, July 1, 2008; 295(1): F42 - F43. [Full Text] [PDF]

				Q. Wei, G. Dong, T. Yang, J. Megyesi, P. M. Price, and Z. Dong Activation and involvement of p53 in cisplatin-induced nephrotoxicity Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1282 - F1291. [Abstract] [Full Text] [PDF]

				E. Garner, F. Martinon, J. Tschopp, P. Beard, and K. Raj Cells with Defective p53-p21-pRb Pathway Are Susceptible to Apoptosis Induced by p84N5 via Caspase-6 Cancer Res., August 15, 2007; 67(16): 7631 - 7637. [Abstract] [Full Text] [PDF]

				F. Yu, J. Megyesi, R. L. Safirstein, and P. M. Price Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity in vitro and in vivo Am J Physiol Renal Physiol, July 1, 2007; 293(1): F52 - F59. [Abstract] [Full Text] [PDF]

				K. Hochegger, C. Koppelstaetter, A. Tagwerker, J. M. Huber, D. Heininger, G. Mayer, and A. R. Rosenkranz p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury Am J Physiol Renal Physiol, February 1, 2007; 292(2): F762 - F768. [Abstract] [Full Text] [PDF]

				J. Wang, N. Pabla, C.-Y. Wang, W. Wang, P. V. Schoenlein, and Z. Dong Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53 Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1300 - F1307. [Abstract] [Full Text] [PDF]

				P. M. Price, F. Yu, P. Kaldis, E. Aleem, G. Nowak, R. L. Safirstein, and J. Megyesi Dependence of Cisplatin-Induced Cell Death In Vitro and In Vivo on Cyclin-Dependent Kinase 2 J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2434 - 2442. [Abstract] [Full Text] [PDF]

				K. A. Nath Provenance of the protective property of p21 Am J Physiol Renal Physiol, September 1, 2005; 289(3): F512 - F513. [Full Text] [PDF]